In-office Placement of the Propel Mini Sinus Implant in the Frontal Sinus Ostia

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

June 30, 2017

Conditions
Chronic Sinusitis
Interventions
DEVICE

PROPEL Mini Sinus Implant

Sinus implant with 370 mcg of mometasone furoate released over 30 days

PROCEDURE

Balloon Sinus Dilation Alone

Trial Locations (9)

10016

Madison ENT, New York

30342

ENT of Georgia, Atlanta

33487

ENT Assoicates of South Florida, Boca Raton

40207

Advanced ENT and Allergy, Louisville

43016

Ohio Sinus Institute, Dublin

64111

St. Luke's ENT Specialists, Kansas City

70433

Associated Surgical Specialists, Covington

87109

BreatheAmerica of Albuquerque, Albuquerque

95815

Sacramento ENT, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Intersect ENT

INDUSTRY

NCT02880514 - In-office Placement of the Propel Mini Sinus Implant in the Frontal Sinus Ostia | Biotech Hunter | Biotech Hunter